miR-363 confers taxane resistance in ovarian cancer by targeting the Hippo pathway member, LATS2

Ovarian cancer is the most aggressive female reproductive tract tumours. Taxane (paclitaxel; TX) is widely used for ovarian cancer treatment. However, ovarian cancers often acquire chemoresistance. MicroRNAs (miR) have been reported to mediate many tumours’chemoresistance. We investigated the role o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed, Zeinab, Hassan, Mohamed Kamel, Okasha, Safwat, Mitamura, Takashi, Keshk, Sarah, Konno, Yusuke, Kato, Tatsuya, EL-Khamisy, Sherif F., Ohba, Yusuke, Watari, Hidemichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059020/
https://www.ncbi.nlm.nih.gov/pubmed/30046387
http://dx.doi.org/10.18632/oncotarget.25698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059020/
https://www.ncbi.nlm.nih.gov/pubmed/30046387
http://dx.doi.org/10.18632/oncotarget.25698

Ejemplares similares